Sentences with phrase «many women with ovarian cancer»

It is now in a phase II clinical trial in women with ovarian cancer, which almost always has p53 mutations.

By the time of diagnosis the majority of women with ovarian cancer already have extensive spread of the disease which makes it difficult to treat by surgery or chemotherapy.

In order to assess whether an improved diet could reduce the risk of ovarian cancer in African - American women, Qin analyzed the diets of 415 women with ovarian cancer and 629 control patients, using data from the African - American Cancer Epidemiology Study, a population - based case - control study of ovarian cancer in African - American women in 11 sites in the United States.

They work to block chemotherapy, which is why nearly every woman with ovarian cancer becomes resistant to treatment.

«This study provided encouraging preliminary results for the use of RT in women with ovarian cancer.»

«What we've discovered will help clinicians to better treat women with ovarian cancer,» says Dr. Ben Tsang, senior scientist at the Ottawa Hospital Research Institute and professor at the University of Ottawa.

An analysis of mutations in the BRCA1 and BRCA2 genes reveals that women with breast cancer and women with ovarian cancer harbored mutations in different regions of the genes.

«This would be an individualized treatment that could increase survival rates of some women with ovarian cancer.»

Nearly 20 percent of women with ovarian cancer do not undergo surgery, despite it being a standard part of treatment recommendations, according to new research from the Perelman School of Medicine at the University of Pennsylvania.

«One in five women with ovarian cancer does not undergo surgery, study reveals: Results show survival benefit of surgery for patients regardless of age or advanced disease, and point to barriers to cancer care delivery.»

«Women with ovarian cancer gain extra months with addition of drug to standard chemotherapy.»

For women with ovarian cancer, a particularly deadly form of gynecologic cancer, even improvements in treatment outcomes have been elusive.

She estimates that about 50 percent of women with ovarian cancer have tumors with this type of tumor and would qualify for the trial, which needs about $ 2 million in philanthropic funding before it could begin.

In their research, scientists at Rutgers created animal models that closely resemble the cancerous tumors found in women with ovarian cancer by injecting tumor tissues obtained from gynecological cancer patients treated at the Cancer Institute into laboratory mice.

For a young woman with ovarian cancer, the options can be grim.

Olaparib was licensed in December for women with ovarian cancer and inherited BRCA mutations, but the new research suggests it could also benefit men with genomic faults within their tumours.

This approach has the potential to provide a novel immunotherapy for women with ovarian cancer.

This holistic approach is revealed in many ways, from helping a young woman with ovarian cancer fulfill her dream of becoming a mother, to helping a chef with tongue cancer preserve his sense of taste.

Guard against ovarian woes When Australian researchers recently compared women with ovarian cancer to cancer - free women, they found that roughly one glass of wine a day seemed to reduce the risk of the disease by as much as 50 percent.

Just 20 % of women with ovarian cancer are cured — meaning the illness never comes back — after undergoing surgery and chemo.

Here's an article posted last week on increased survival for women with ovarian cancer with high vitamin D levels: http://www.vitamindcouncil.org/blog/new-study-suggests-vitamin-d-status-is-a-predictor-of-survival-among-women-with-ovarian-cancer/

The investigators discovered that women with ovarian cancer linked to genes inherited from their father's mother developed the cancer much earlier than those with ovarian cancer linked to genes from their mother.

However, many women with ovarian cancer disagree.

New research from the Cancer Research Center in Seattle shows that women with ovarian cancer are much more likely than healthy women to report symptoms such as abdominal pain, bloating and feeling full quickly after eating.

It is committed to improving survival for women with ovarian cancer through early diagnosis and pioneering scientific research.

Not exact matches

The drug is meant for women with advanced ovarian cancer who have already been treated with two or more chemotherapies.

Yet 20 % of women diagnosed with lung cancer each year — about 21,000 in 2010, roughly the same number as new cases of ovarian cancer — never smoked.

Therefore, the overwhelming majority of women who are diagnosed with ovarian cancer do not sue claiming that someone should have figured it out sooner.

Women for whom genetic testing is recommended are: women who are diagnosed with breast cancer under the age of 50, are of Ashkenazi ancestry, have bilateral breast cancer, have ovarian cancer, have triple negative breast cancer, or have 2 or more family members with breast caWomen for whom genetic testing is recommended are: women who are diagnosed with breast cancer under the age of 50, are of Ashkenazi ancestry, have bilateral breast cancer, have ovarian cancer, have triple negative breast cancer, or have 2 or more family members with breast cawomen who are diagnosed with breast cancer under the age of 50, are of Ashkenazi ancestry, have bilateral breast cancer, have ovarian cancer, have triple negative breast cancer, or have 2 or more family members with breast cancer.

Examples might include a 30 - year - old healthy woman without a family history of ovarian cancer wanting to have her ovaries removed to prevent such a cancer; a woman with fibroids wanting an experimental surgical treatment whose long - term effects are still unknown; or an 18 - year - old woman without children wanting a sterilization procedure.

For women who choose to breastfeed there are lower risks associated with breast and ovarian cancer, less chance of hip fractures and osteoporosis in later life, and the added benefit that it helps with getting back to their pre-baby weight.

Recent research demonstrates that lactating women have an earlier return to prepregnant weight, 41 delayed resumption of ovulation with increased child spacing,42 - 44 improved bone remineralization postpartum45 with reduction in hip fractures in the postmenopausal period, 46 and reduced risk of ovarian cancer47 and premenopausal breast cancer.48

Enabling women to breastfeed is also a public health priority because, on a population level, interruption of lactation is associated with adverse health outcomes for the woman and her child, including higher maternal risks of breast cancer, ovarian cancer, diabetes, hypertension, and heart disease, and greater infant risks of infectious disease, sudden infant death syndrome, and metabolic disease (2, 4).

Part of my mission is to share information about ovarian cancer with women in order to help them understand the risk factors, symptoms and precautions to promote early detection and reduce ovarian cancer related deaths.

For that reason, the American Cancer Society recommends annual MRI screenings only in women with a strong family history of breast or ovarian cCancer Society recommends annual MRI screenings only in women with a strong family history of breast or ovarian cancercancer.

Many doctors who no longer advise mammograms for most women younger than 50 continue to suggest them for those with a family history of breast or ovarian cancer.

In reality, it turns out that many women with high levels of CA 125 do not have ovarian cancer, and, conversely, many women with cancer do not have high levels of CA 125.

Thousands of women are living with ovarian cancer in Canada.

Among postmenopausal women, the women with the highest quartile of HEI - 2010 scores were 43 percent less likely to be diagnosed with ovarian cancer, and the women with the highest quartile AHEI - 2010 scores were 51 percent less likely to be diagnosed with ovarian cancer than the women in the lowest quartile.

Qin said that among all African - American women in the study, those with the highest adherence to an AHEI - 2010 diet were 34 percent less likely to be diagnosed with ovarian cancer than women with the lowest AHEI - 2010 adherence.

Because ovarian cancer is relatively rare, occurring in approximately one out of every 2,500 women, a test with only 99 percent specificity would result in false - positive diagnoses for 25 women, leading to unnecessary and risky surgeries and procedures.

Researchers at the Georgia Institute of Technology collected blood from 44 women diagnosed with ovarian cancer at various stages, along with that from 50 healthy controls.

But Weidhaas and Slack's studies showed how the KRAS - variant increases a woman's risk of ovarian cancer — more than 27 percent of women with this type of cancer carried the variant.

One patient, a 46 - year old woman, started the trial with stage 4 ovarian cancer — which generally has a very poor prognosis — following five prior courses of chemotherapy.

The study, which compared each model's success in Caucasian women with those of Asian descent (Chinese, Japanese, Filipino, Korean and Vietnamese), also raised important questions about the effect of race on cancer development: When Caucasian and Asian patients with similar family histories of breast and ovarian cancer were compared, the Asian women had higher rates of genetic mutation, although the rates of these cancers for Asians have traditionally been lower.

It is estimated that 2,700 Canadian women will be diagnosed with ovarian cancer in 2014 and that 1,750 Canadian women will die from the disease, according to Ovarian Cancer ovarian cancer in 2014 and that 1,750 Canadian women will die from the disease, according to Ovarian Cancer Ccancer in 2014 and that 1,750 Canadian women will die from the disease, according to Ovarian Cancer Ovarian Cancer CCancer Canada.

Women with a family history of two or more immediate family members (mother, sister, daughter) with breast or ovarian cancer or with a positive genetic test for mutations in the BRCA1 or BRCA2 genes may be advised to consider having both breasts removed, because they are at high risk of a new cancer developing in the other breast.

TRINOVA - 1 was a randomized prospective phase III clinical trial that added trebananib or placebo to standard chemotherapy (weekly paclitaxel) among 919 women with recurrent ovarian cancer patient from 179 sites in 32 countries.

Those in the heaviest group, women with a BMI over 28, had only 52 percent the ovarian cancer incidence of recruits in the leanest group, those with a BMI of 23 and under.

If true, that might explain the cancer difference because women with more body fat tend to develop a different hormonal profile than leaner ones and ovarian cancer is a hormone - sensitive malignancy.